Once again, the result of Kaplan–Meier survival analysis, ROC curve, univariate and multivariate analyses, and Meta-analysis was confirmed that GINS4 could be used as an independent prognostic factor to predict poor prognosis in patients with glioma. The gene discussed is GINS4; the disease is central nervous system cancer.